• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Desiderata for Major Eligibility Criteria in Breast Cancer Clinical Trials.乳腺癌临床试验主要入选标准的必备条件
AMIA Annu Symp Proc. 2015 Nov 5;2015:2025-34. eCollection 2015.
2
Supporting patient screening to identify suitable clinical trials.支持患者筛查以确定合适的临床试验。
Stud Health Technol Inform. 2014;205:823-7.
3
A review of research on eligibility criteria for clinical trials.临床试验入选标准研究述评。
Clin Exp Med. 2023 Oct;23(6):1867-1879. doi: 10.1007/s10238-022-00975-1. Epub 2023 Jan 5.
4
A data-driven approach to optimizing clinical study eligibility criteria.基于数据的临床研究纳入标准优化方法。
J Biomed Inform. 2023 Jun;142:104375. doi: 10.1016/j.jbi.2023.104375. Epub 2023 May 2.
5
Eligibility criteria in randomized phase II and III adjuvant and neoadjuvant breast cancer trials: not a significant barrier to enrollment.随机 II 期和 III 期辅助和新辅助乳腺癌试验的纳入标准:不是入组的显著障碍。
Clin Trials. 2012 Oct;9(5):652-9. doi: 10.1177/1740774512456453.
6
Semantic query generation from eligibility criteria in clinical trials.从临床试验的纳入标准生成语义查询。
AMIA Annu Symp Proc. 2007 Oct 11:1070.
7
Increasing minority patient participation in cancer clinical trials using oncology nurse navigation.利用肿瘤护士导航增加少数族裔患者参与癌症临床试验。
Am J Surg. 2012 Apr;203(4):415-22. doi: 10.1016/j.amjsurg.2011.02.005. Epub 2011 Oct 13.
8
Automated classification of eligibility criteria in clinical trials to facilitate patient-trial matching for specific patient populations.对临床试验中的入选标准进行自动分类,以促进针对特定患者群体的患者与试验匹配。
J Am Med Inform Assoc. 2017 Jul 1;24(4):781-787. doi: 10.1093/jamia/ocw176.
9
Automatic trial eligibility surveillance based on unstructured clinical data.基于非结构化临床数据的自动试验资格监测。
Int J Med Inform. 2019 Sep;129:13-19. doi: 10.1016/j.ijmedinf.2019.05.018. Epub 2019 May 23.
10
Artificial Intelligence Tool for Optimizing Eligibility Screening for Clinical Trials in a Large Community Cancer Center.人工智能工具用于优化大型社区癌症中心临床试验的资格筛选。
JCO Clin Cancer Inform. 2020 Jan;4:50-59. doi: 10.1200/CCI.19.00079.

引用本文的文献

1
The Data Gap in the EHR for Clinical Research Eligibility Screening.电子健康记录用于临床研究资格筛查的数据缺口
AMIA Jt Summits Transl Sci Proc. 2018 May 18;2017:320-329. eCollection 2018.
2
GIST 2.0: A scalable multi-trait metric for quantifying population representativeness of individual clinical studies.GIST 2.0:一种用于量化个体临床研究人群代表性的可扩展多特征指标。
J Biomed Inform. 2016 Oct;63:325-336. doi: 10.1016/j.jbi.2016.09.003. Epub 2016 Sep 4.

本文引用的文献

1
Analysis of eligibility criteria representation in industry-standard clinical trial protocols.分析行业标准临床试验方案中纳入标准的表述。
J Biomed Inform. 2013 Oct;46(5):805-13. doi: 10.1016/j.jbi.2013.06.001. Epub 2013 Jun 12.
2
EliXR-TIME: A Temporal Knowledge Representation for Clinical Research Eligibility Criteria.EliXR-TIME:一种用于临床研究资格标准的时间知识表示法。
AMIA Jt Summits Transl Sci Proc. 2012;2012:71-80. Epub 2012 Mar 19.
3
A real-time screening alert improves patient recruitment efficiency.实时筛查警报可提高患者招募效率。
AMIA Annu Symp Proc. 2011;2011:1489-98. Epub 2011 Oct 22.
4
Systems biology: confronting the complexity of cancer.系统生物学:直面癌症的复杂性。
Cancer Res. 2011 Sep 15;71(18):5961-4. doi: 10.1158/0008-5472.CAN-11-1569. Epub 2011 Sep 6.
5
EliXR: an approach to eligibility criteria extraction and representation.EliXR:一种资格标准提取和表示方法。
J Am Med Inform Assoc. 2011 Dec;18 Suppl 1(Suppl 1):i116-24. doi: 10.1136/amiajnl-2011-000321. Epub 2011 Jul 31.
6
A practical method for transforming free-text eligibility criteria into computable criteria.一种将自由文本资格标准转化为可计算标准的实用方法。
J Biomed Inform. 2011 Apr;44(2):239-50. doi: 10.1016/j.jbi.2010.09.007. Epub 2010 Sep 17.
7
Formal representation of eligibility criteria: a literature review.资格标准的形式化表示:文献综述。
J Biomed Inform. 2010 Jun;43(3):451-67. doi: 10.1016/j.jbi.2009.12.004. Epub 2009 Dec 23.
8
Feasibility trial of letrozole in combination with bevacizumab in patients with metastatic breast cancer.来曲唑联合贝伐珠单抗治疗转移性乳腺癌的可行性研究。
J Clin Oncol. 2010 Feb 1;28(4):628-33. doi: 10.1200/JCO.2009.21.8784. Epub 2009 Oct 19.
9
Metabolomics-based systems biology and personalized medicine: moving towards n = 1 clinical trials?基于代谢组学的系统生物学与个性化医疗:迈向单一个体(n = 1)临床试验?
Pharmacogenomics. 2006 Oct;7(7):1087-94. doi: 10.2217/14622416.7.7.1087.
10
Embracing the complexity of genomic data for personalized medicine.为实现个性化医疗而接受基因组数据的复杂性。
Genome Res. 2006 May;16(5):559-66. doi: 10.1101/gr.3851306.

乳腺癌临床试验主要入选标准的必备条件

Desiderata for Major Eligibility Criteria in Breast Cancer Clinical Trials.

作者信息

Paulson Matthew L, Weng Chunhua

机构信息

Department of Biomedical Informatics, Columbia University, New York, NY.

出版信息

AMIA Annu Symp Proc. 2015 Nov 5;2015:2025-34. eCollection 2015.

PMID:26958302
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4765677/
Abstract

Use of major eligibility criteria is a popular but unstudied folk practice for improving patient screening efficiency for clinical studies. This mixed-methods research study derived the desiderata for major eligibility criteria in breast cancer clinical trials. We randomly selected thirty interventional breast cancer clinical trials conducted at The New York-Presbyterian Hospital on the Columbia University Medical Center campus to create training (N=20) and testing (N=10) datasets. We utilized the Think-aloud protocol to gauge how clinical researchers identify and use major eligibility criteria to prescreen patients for clinical trials during an audio-recorded interview. A focus group session was held to understand the current prescreening process and investigate how it could be optimized to maximize recruitment rates. Using the grounded theory method, we annotated transcriptions to discover user rationale and desiderata behind major eligibility criteria in breast cancer clinical trials, which were later evaluated in a follow-up survey.

摘要

使用主要入选标准是一种流行但未经研究的民间做法,用于提高临床研究患者筛选效率。这项混合方法研究得出了乳腺癌临床试验主要入选标准的要求。我们从纽约长老会医院哥伦比亚大学医学中心校区进行的30项介入性乳腺癌临床试验中随机选取,创建了训练数据集(N = 20)和测试数据集(N = 10)。我们采用出声思维协议,通过录音访谈来衡量临床研究人员如何识别和使用主要入选标准对患者进行临床试验预筛选。举行了焦点小组会议,以了解当前的预筛选过程,并研究如何对其进行优化以最大化招募率。我们使用扎根理论方法对转录内容进行注释,以发现乳腺癌临床试验中主要入选标准背后的用户基本原理和要求,随后在后续调查中对其进行评估。